Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-07 · accession 0001567619-23-003004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-14 | 2023-02-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $67.81 | +21.0K | 335.3K | +7% | +$1.42M |
| DM | 2023-02-14 | 2023-02-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $109.84 | -21.0K | 320.3K | -6% | -$2.31M |
| DMI | 2023-02-14 | 2023-02-07 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | G - Gift | $0.00 | 0 | 247.3K | New | $0 |
| DM | 2023-02-14 | 2023-02-10 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -21.0K | 172.1K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | M | A | 6,000 | $67.81 | 326,324 | D | — | — | (F3) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |
| 2 | Common | Common Stock | 2023-02-10 | S | D | 15,000 | $110.11 | 320,324 | D | — | — | (F3) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |
| 3 | Common | Common Stock | 2023-02-10 | M | A | 15,000 | $67.81 | 335,324 | D | — | — | (F3) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |
| 4 | Common | Common Stock | 2023-02-07 | G | A | 100 | $0.00 | 100 | I Shares held as UTMA custodian for child | — | — | |
| 5 | Common | Common Stock | 2023-02-07 | G | A | 100 | $0.00 | 100 | I Shares held as UTMA custodian for child | — | — | |
| 6 | Common | Common Stock | 2023-02-13 | S | D | 6,000 | $109.15 | 320,324 | D | — | — | (F3) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |
| 7 | Common | Common Stock | 2023-02-07 | G | D | 200 | $0.00 | 247,333 | I Shares held by Jean-Jacques Bienaime Family Trust | — | — | |
| 8 | Derivative | Stock Option (Right to buy Common Stock) | 2023-02-10 | M | D | 15,000 | $0.00 | 178,130 | D | $67.81 · 2013-11-15 to 2023-05-14 | 15,000 Common Stock | (F3) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. (F1) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 9 | Derivative | Stock Option (Right to buy Common Stock) | 2023-02-10 | M | D | 6,000 | $0.00 | 172,130 | D | $67.81 · 2013-11-15 to 2023-05-14 | 6,000 Common Stock | (F3) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. (F1) Reflects the number of options outstanding after the transactions from this specific stock option grant. |